1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bone Marrow Transplant Market, By Transplant Type
5.1 Introduction
5.2 Autologous Bone Marrow Transplant
5.3 Allogeneic Bone marrow Transplant
5.4 Other Transplant Types
6 Global Bone Marrow Transplant Market, By Disease Indication
6.1 Introduction
6.2 Leukemia
6.3 Lymphoma
6.4 Myeloma
6.5 Thalassemia
6.6 Myelodysplastic Syndrome
6.7 Myeloproliferative Disorders
6.8 Aplastic Anemia
6.9 Solid Tumors
6.10 Sickle cell Anemia
6.11 Other Disease Indications
7 Global Bone Marrow Transplant Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Multispecialty Clinics
7.4 Ambulatory Surgical Centers
7.5 Other End Users
8 Global Bone Marrow Transplant Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Gamida Cell Ltd.
10.2 Mesoblast Ltd.
10.3 American Type Culture Collection (ATCC) Inc
10.4 Lonza Group Ltd.
10.5 FUJIFILM Cellular Dynamics, Inc.
10.6 ReachBio LLC.
10.7 Sanofi-Aventis LLC.
10.8 PromoCell GmbH
10.9 Abbott Laboratories Inc
10.10 The Emmes Company LLC
10.11 CORESTEM, Inc.
10.12 StemCell Technologies.
10.13 Hemacare Corporation
10.14 AllCells LLC.
10.15 Lifeline Cell Technology LLC
10.16 ReeLabs Pvt. Ltd.
10.17 Charles River Laboratories
10.18 Merck Millipore Corporation
List of Tables
Table 1 Global Bone Marrow Transplant Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 3 Global Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 4 Global Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 5 Global Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 6 Global Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 7 Global Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 8 Global Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 9 Global Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 10 Global Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 11 Global Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 12 Global Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 13 Global Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 14 Global Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 15 Global Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 16 Global Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 17 Global Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 18 Global Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 19 Global Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 20 Global Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 21 Global Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
Table 22 North America Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
Table 23 North America Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 24 North America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 25 North America Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 26 North America Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 27 North America Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 28 North America Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 29 North America Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 30 North America Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 31 North America Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 32 North America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 33 North America Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 34 North America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 35 North America Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 36 North America Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 37 North America Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 38 North America Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 39 North America Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 40 North America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 41 North America Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 42 North America Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
Table 43 Europe Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
Table 44 Europe Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 45 Europe Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 46 Europe Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 47 Europe Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 48 Europe Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 49 Europe Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 50 Europe Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 51 Europe Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 52 Europe Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 53 Europe Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 54 Europe Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 55 Europe Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 56 Europe Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 57 Europe Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 58 Europe Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 59 Europe Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 60 Europe Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 61 Europe Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 62 Europe Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 63 Europe Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
Table 64 Asia Pacific Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
Table 65 Asia Pacific Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 66 Asia Pacific Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 67 Asia Pacific Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 68 Asia Pacific Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 69 Asia Pacific Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 70 Asia Pacific Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 71 Asia Pacific Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 72 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 73 Asia Pacific Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 74 Asia Pacific Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 75 Asia Pacific Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 76 Asia Pacific Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 77 Asia Pacific Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 78 Asia Pacific Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 79 Asia Pacific Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 80 Asia Pacific Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 81 Asia Pacific Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 82 Asia Pacific Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 83 Asia Pacific Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 84 Asia Pacific Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
Table 85 South America Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
Table 86 South America Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 87 South America Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 88 South America Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 89 South America Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 90 South America Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 91 South America Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 92 South America Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 93 South America Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 94 South America Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 95 South America Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 96 South America Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 97 South America Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 98 South America Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 99 South America Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 100 South America Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 101 South America Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 102 South America Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 103 South America Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 104 South America Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 105 South America Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
Table 106 Middle East & Africa Bone Marrow Transplant Market Outlook, By Country (2021-2030) ($MN)
Table 107 Middle East & Africa Bone Marrow Transplant Market Outlook, By Transplant Type (2021-2030) ($MN)
Table 108 Middle East & Africa Bone Marrow Transplant Market Outlook, By Autologous Bone Marrow Transplant (2021-2030) ($MN)
Table 109 Middle East & Africa Bone Marrow Transplant Market Outlook, By Allogeneic Bone marrow Transplant (2021-2030) ($MN)
Table 110 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other Transplant Types (2021-2030) ($MN)
Table 111 Middle East & Africa Bone Marrow Transplant Market Outlook, By Disease Indication (2021-2030) ($MN)
Table 112 Middle East & Africa Bone Marrow Transplant Market Outlook, By Leukemia (2021-2030) ($MN)
Table 113 Middle East & Africa Bone Marrow Transplant Market Outlook, By Lymphoma (2021-2030) ($MN)
Table 114 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myeloma (2021-2030) ($MN)
Table 115 Middle East & Africa Bone Marrow Transplant Market Outlook, By Thalassemia (2021-2030) ($MN)
Table 116 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myelodysplastic Syndrome (2021-2030) ($MN)
Table 117 Middle East & Africa Bone Marrow Transplant Market Outlook, By Myeloproliferative Disorders (2021-2030) ($MN)
Table 118 Middle East & Africa Bone Marrow Transplant Market Outlook, By Aplastic Anemia (2021-2030) ($MN)
Table 119 Middle East & Africa Bone Marrow Transplant Market Outlook, By Solid Tumors (2021-2030) ($MN)
Table 120 Middle East & Africa Bone Marrow Transplant Market Outlook, By Sickle cell Anemia (2021-2030) ($MN)
Table 121 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other Disease Indications (2021-2030) ($MN)
Table 122 Middle East & Africa Bone Marrow Transplant Market Outlook, By End User (2021-2030) ($MN)
Table 123 Middle East & Africa Bone Marrow Transplant Market Outlook, By Hospitals (2021-2030) ($MN)
Table 124 Middle East & Africa Bone Marrow Transplant Market Outlook, By Multispecialty Clinics (2021-2030) ($MN)
Table 125 Middle East & Africa Bone Marrow Transplant Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
Table 126 Middle East & Africa Bone Marrow Transplant Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 骨髄移植は、血液の細胞を生成する機能を持つ骨髄を移植する医療行為です。この治療法は、主に血液疾患や特定のがん、先天性の免疫不全症などを治療するために用いられます。骨髄が正常に機能しなくなると、貧血や感染症、出血のリスクが高まるため、移植によって新たな健康な骨髄を提供し、これらの問題を改善することができます。 骨髄移植には主に3つの種類があります。一つ目は、自家移植です。これは患者自身の骨髄を使用する方法で、事前に健康な骨髄を採取し、治療後に戻します。この方法は免疫反応が起こりにくく、合併症のリスクが低い特徴がありますが、がん治療を行う場合には、がん細胞が残る可能性があります。 二つ目は、同種移植です。これは他人の骨髄を使用する方法で、適合するドナーが必要です。同種移植には、兄弟や親、あるいはドナー登録から選ばれる非血縁者が提供者になる場合があります。この方法は、他人の健康な骨髄ががんや病気に侵された患者に新しい細胞を提供するため、治療の可能性が広がりますが、拒絶反応や移植後の合併症が考慮されます。 三つ目は、臍帯血移植です。これは新生児の臍帯血を利用する方法で、臍帯血には多くの幹細胞が含まれており、移植後の再生タスクに役立ちます。この方法は、ドナーの適合に関する制約が少ないため、さまざまな患者に対して対応可能な選択肢となっています。 骨髄移植の主な用途は、白血病、悪性リンパ腫、多発性骨髄腫、再生不良性貧血、先天性免疫不全症などの治療です。これらの疾患では、骨髄や血液を作成する能力が低下または失われるため、新たな骨髄細胞が必要となります。移植によって、新しい血液細胞が生成され、患者の健康が回復することを目指します。 関連技術としては、幹細胞治療が挙げられます。幹細胞は、特定の組織や臓器の細胞に分化する能力を持ち、再生医療において重要な役割を果たします。骨髄移植の場合、移植された幹細胞が新しい血液細胞に分化し、患者の体内で機能します。また、細胞療法や遺伝子治療も関連技術として進化しており、これらは特定の遺伝的疾患や感染症の治療に新たなアプローチを提供しています。 骨髄移植は、患者にとって希望の光となる一方で、高度な医療技術と専門知識が必要です。移植手術自体は高度な技術を要し、慎重に行われます。その後の管理やフォローアップも重要で、定期的な診察や血液検査が必要です。 移植後には、感染症や合併症のリスクがあるため、患者は医療チームと密接に連携することが求められます。また、移植に伴う拒絶反応を防ぐための免疫抑制療法も行われますが、これには副作用が伴うこともあります。 骨髄移植は、時には患者の生命を救う治療法となることも多いですが、その成功率は、患者の健康状態や年齢、移植を受ける疾患の種類によって異なります。そのため、医療の進歩とともに、新たな治療法や支援体制が整備されることが求められています。最近では、移植の成功率を上げるための研究が進められ、患者に対する支援もより充実してきています。 このように、骨髄移植は様々な疾患に対する重要な治療法であり、患者にとって希望のある選択肢となっています。治療に関わる医療者と患者の連携が、成功の鍵となるでしょう。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
